EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis

Bernhard Nagler, Thomas Staudinger, Peter Schellongowski, Paul Knoebl, Roman Brock, Andrea Kornfehl, Michael Schwameis, Harald Herkner, Jerrold H Levy, Nina Buchtele

Journal of Thrombosis and Haemostasis · 2024-10 · 22 (10) · 2773-2783

DOI: 10.1016/j.jtha.2024.06.008 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-10. Verfasst von Bernhard Nagler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I - Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria. Electronic address: https://twitter.com/bernhardn…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heparin, Anticoagulants, Drug Resistance. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Unfractionated heparin (UFH) is used in most centers for extracorporeal membrane oxygenation (ECMO) anticoagulation. When standard doses do not achieve desired target values, heparin resistance is reported, most commonly defined as doses of UFH > 35 000 IU/d. OBJECTIVES: To study the incidence of heparin resistance and its association with thromboembolic complications in patients requiring ECMO support. METHODS: In this observational cohort study, we included adults who received venovenous, venoarterial ECMO and extracorporeal carbon dioxide removal between January 2010 and May 2022. Main risk factor was heparin resistance (UFH, > 35 000 IU/d or > 20 IU/kg/h); the outcome was thromboembolism. Multivariable Poisson regression was used to estimate the effects of heparin resistance, adjusted for several clinical variables on the thromboembolism rate per 100 ECMO patient-days. RESULTS: Of the 197 patients included, 33 (16.8%) required UFH > 35 000 IU/d and 14 (7.1%) required UFH > 20 IU/kg/h. Thromboembolic complications occurred at a rate of 5.89/100 ECMO d. Heparin resistance was not associated with thromboembolic events (incidence rate ratio [IRR], 0.93; 95% CI, 0.14-5.82), whereas COVID-19 (IRR, 2.33; 95% CI, 1.4-3.96; P < .001) and ECMO type (venoarterial ECMO: IRR, 2.29; 95% CI, 1.34-3.92; P = .002; extracorporeal carbon dioxide removal: IRR, 2.89; 95% CI, 1.46-5.59; P = .002; reference venovenous ECMO) were significantly associated with the risk of thromboembolic events. CONCLUSION: A significant proportion of patients fulfilled the common definition of heparin resistance. However, this did not influence the occurrence of thromboembolic events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHeparinAnticoagulantsDrug ResistanceThromboembolismHumansFemaleMaleRetrospective StudiesMiddle AgedIncidenceAdultRisk FactorsAged

Stichwörter der Autor:innen

anticoagulantsextracorporeal membrane oxygenationheparinthromboembolism

Substanzen

HeparinAnticoagulants

Autor:innen und Institutionen

  • Department of Medicine I - Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria. Electronic address: https://twitter.com/bernhardnagler.
  • Department of Medicine I - Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.staudinger@meduniwien.ac.at.
  • Department of Medicine I - Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
  • Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Durham, North Carolina, USA.

Zitieren

APA

Nagler, B., Staudinger, T., Schellongowski, P., Knoebl, P., Brock, R., Kornfehl, A., Schwameis, M., Herkner, H., Levy, J. H., & Buchtele, N. (2024). Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis. Journal of Thrombosis and Haemostasis, 22(10), 2773-2783. https://doi.org/10.1016/j.jtha.2024.06.008

Vancouver

Nagler B, Staudinger T, Schellongowski P, Knoebl P, Brock R, Kornfehl A, et al. Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis. Journal of Thrombosis and Haemostasis. 2024;22(10):2773-2783. doi:10.1016/j.jtha.2024.06.008

BibTeX
@article{Nagler2024,
  author = {Nagler, Bernhard and Staudinger, Thomas and Schellongowski, Peter and Knoebl, Paul and Brock, Roman and Kornfehl, Andrea and Schwameis, Michael and Herkner, Harald and Levy, Jerrold H and Buchtele, Nina},
  title = {Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  volume = {22},
  number = {10},
  pages = {2773--2783},
  doi = {10.1016/j.jtha.2024.06.008}
}
Kostenlos starten →